Articles & Video
Clinical Trials 2020 Digital Week: Full list of live webcasts
From remote trials to patient technology, we reveal the live webcast sessions running in this year's Clinical Trials Digital Week on June 1-4.
Clinical Trials Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in clinical trials with one simple registration.
The Top 10 Posts of 2019: Clinical Trials Innovation
We look back at 2019's most popular articles on innovating clinical trials in an interactive flip-book.
How far can we trust AI in clinical trials?- INDUSTRY VOICES
Seven industry experts tell us what they see as the greatest challenges in using AI in clinical trials and how they can best be solved.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
Clinical Trials State of the Industry Report 2019
Clinical Trials State of the Industry 2019: Download the report offering insights into wearables, AI, virtual trials, partnerships and vendor oversight.
Clinical Trials Digital Week 2019 - 7 webinars on-demand
Register for Clinical Trials Digital Week 2019 for on-demand webinars and downloadable resources.
Low literacy issues and the Patient Information Leaflet
Former a senior research nurse Kate O’Brien looks at how low literacy levels in the UK present a challenge to effective Patient Information Leaflets for clinical trials.
Leveraging Real World Evidence for drug approval
Since the introduction of the 21st Century Cures Act real world evidence has been gaining in popularity. We look at the opportunities and challenges it presents.
Real World Evidence: Revolutionizing the Clinical Trials Environment - WHITEPAPER
Download this exclusive whitepaper exploring how Real World Evidence is revolutionizing the clinical trials environment.
Increasing research awareness and changing public perception of clinical trials
Site consultant Kate O’Brien looks at ways to increase research awareness to help boost patient engagement in clinical trials.
The Pain Clinic - Solving the five most common problems in clinical trials
Kate O’Brien examines the most common problems in all aspects of running clinical trials and the potential solutions to them.
How Virtual Trials and Real World Evidence are changing the CRO landscape
Dr. Raphaela Schnurbus, Clinical Solutions & Business Development Director at CRO OPIS, explores how Virtual Trials and Real World Evidence could change the clinical trials of the future.
The 10 most read posts of 2018
The 10 most read clinical trials posts of 2018 on data, patient-centricity, AI, partnerships and recruitment.
Real-World-Evidence Mythbusting: 5 myths holding back patient-reported RWE adoption
What is holding back patient-reported Real-World-Evidence adoption in clinical trials? Bruce Hellman, CEO and Co-founder at uMotif, busts 5 myths.
Forming clinical trial consortia is "definitely the future" - Dr. Raphaela Schnurbus
Dr. Raphaela Schnurbus, Clinical Solutions Director at CRO OPIS, discusses how partnerships in clinical trials are evolving and the challenges that still need to be overcome.
How a patient and doctors worked together to form innovative non-profit OurBrainBank
Jessica Morris tells the story of how she created the non-profit OurBrainBank after being diagnosed with glioblastoma (GBM) in 2016.
How full virtual clinical trials can become reality in the next 10 years
How can virtual clinical trials be implemented in the next 10 years through EHRs, synthetic biology and nanopores? Michelle Petersen takes a deep dive.
Why patient recruitment is the biggest challenge in clinical trials – INDUSTRY VOICES
Six clinical insiders offer their views on the challenge of patient recruitment in clinical trials and how they are dealing with it.
The potential of smart adherence tools in clinical trials
Dr Hilde Vanaken, Clinical Innovation Director at Janssen, explores the opportunities around smart adherence tools as well as the implementation barriers.